116 related articles for article (PubMed ID: 38844019)
1. In vitro characterization of protonitazene metabolites, using human liver microsomes, and first application to two urines collected from death cases.
Ameline A; Gheddar L; Pichini S; Stove C; Aknouche F; Maruejouls C; Raul JS; Kintz P
Clin Chim Acta; 2024 Jun; 561():119764. PubMed ID: 38844019
[TBL] [Abstract][Full Text] [Related]
2. A Forward-Thinking Approach to Addressing the New Synthetic Opioid 2-Benzylbenzimidazole Nitazene Analogs by Liquid Chromatography-Tandem Quadrupole Mass Spectrometry (LC-QQQ-MS).
Walton SE; Krotulski AJ; Logan BK
J Anal Toxicol; 2022 Mar; 46(3):221-231. PubMed ID: 34792157
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of highly potent synthetic opioid nitazene analogs: N-ethyl-N-(1-glucuronyloxyethyl) metabolite formation and degradation to N-desethyl metabolites during enzymatic hydrolysis.
Kanamori T; Okada Y; Segawa H; Yamamuro T; Kuwayama K; Tsujikawa K; Iwata YT
Drug Test Anal; 2024 Apr; ():. PubMed ID: 38679851
[TBL] [Abstract][Full Text] [Related]
4. High-throughput quantification of emerging "nitazene" benzimidazole opioid analogs by microextraction and UHPLC-MS-MS.
Schüller M; Lucic I; Øiestad ÅML; Pedersen-Bjergaard S; Øiestad EL
J Anal Toxicol; 2023 Dec; 47(9):787-796. PubMed ID: 37700512
[TBL] [Abstract][Full Text] [Related]
5. In vitro structure-activity relationships and forensic case series of emerging 2-benzylbenzimidazole 'nitazene' opioids.
De Vrieze LM; Walton SE; Pottie E; Papsun D; Logan BK; Krotulski AJ; Stove CP; Vandeputte MM
Arch Toxicol; 2024 Jun; ():. PubMed ID: 38877156
[TBL] [Abstract][Full Text] [Related]
6. Elucidating the Gas-Phase Behavior of Nitazene Analog Protomers Using Structures for Lossless Ion Manipulations Ion Mobility-Orbitrap Mass Spectrometry.
Hollerbach AL; Lin VS; Ibrahim YM; Ewing RG; Metz TO; Rodda KE
J Am Soc Mass Spectrom; 2024 Jun; ():. PubMed ID: 38907730
[TBL] [Abstract][Full Text] [Related]
7. Testing for protonitazene in human hair using LC-MS/MS.
Kintz P; Ameline A; Gheddar L; Pichini S; Mazoyer C; Teston K; Aknouche F; Maruejouls C
J Anal Toxicol; 2024 Jun; ():. PubMed ID: 38836591
[TBL] [Abstract][Full Text] [Related]
8. Metabolites to parent 3-MeO-PCP ratio in human urine collected in two fatal cases.
Ameline A; Greney H; Monassier L; Raul JS; Kintz P
J Anal Toxicol; 2019 May; 43(4):321-324. PubMed ID: 30476158
[TBL] [Abstract][Full Text] [Related]
9. Analysis of highly potent synthetic opioid nitazene analogs and their positional isomers.
Kanamori T; Okada Y; Segawa H; Yamamuro T; Kuwayama K; Tsujikawa K; Iwata YT
Drug Test Anal; 2023 Apr; 15(4):449-457. PubMed ID: 36437623
[TBL] [Abstract][Full Text] [Related]
10. Identification of N-pyrrolidino protonitazene in powders sold as heroin and associated with overdose clusters in Dublin and Cork, Ireland.
Killoran S; McNamara S; Kavanagh P; O'Brien J; Lakes R
Drug Test Anal; 2024 May; ():. PubMed ID: 38769669
[TBL] [Abstract][Full Text] [Related]
11.
Berardinelli D; Taoussi O; Carlier J; Tini A; Zaami S; Sundermann T; Busardò FP; Auwärter V
Clin Chem Lab Med; 2024 Jul; 62(8):1580-1590. PubMed ID: 38311816
[TBL] [Abstract][Full Text] [Related]
12. In vitro characterization of S-23 metabolites produced by human liver microsomes, and subsequent application to urine after a controlled oral administration.
Ameline A; Gheddar L; Raul JS; Kintz P
J Pharm Biomed Anal; 2022 Apr; 212():114660. PubMed ID: 35182830
[TBL] [Abstract][Full Text] [Related]
13. Study of the in vitro and in vivo metabolism of the tryptamine 5-MeO-MiPT using human liver microsomes and real case samples.
Grafinger KE; Hädener M; König S; Weinmann W
Drug Test Anal; 2018 Mar; 10(3):562-574. PubMed ID: 28677880
[TBL] [Abstract][Full Text] [Related]
14. In vitro characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high resolution MS.
Boumrah Y; Humbert L; Phanithavong M; Khimeche K; Dahmani A; Allorge D
Drug Test Anal; 2016 Feb; 8(2):248-56. PubMed ID: 26382567
[TBL] [Abstract][Full Text] [Related]
15. Wastewater-based monitoring of the nitazene analogues: First detection of protonitazene in wastewater.
Bade R; Nadarajan D; Driver EM; Halden RU; Gerber C; Krotulski A; Hall W; Mueller JF
Sci Total Environ; 2024 Apr; 920():170781. PubMed ID: 38360322
[TBL] [Abstract][Full Text] [Related]
16. Methyl (S)-2-(1-7 (5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (5F-MDMB-PICA) intoxication in a child with identification of two new metabolites (ultra-high-performance liquid chromatography-tandem mass spectrometry).
Szpot P; Nowak K; Wachełko O; Tusiewicz K; Chłopaś-Konowałek A; Zawadzki M
Forensic Toxicol; 2023 Jan; 41(1):47-58. PubMed ID: 36652054
[TBL] [Abstract][Full Text] [Related]
17. Metabolic profiling of deschloro-N-ethyl-ketamine and identification of new target metabolites in urine and hair using human liver microsomes and high-resolution accurate mass spectrometry.
Larabi IA; Zerizer F; Ameline A; Etting I; Joseph D; Kintz P; Alvarez JC
Drug Test Anal; 2021 Jun; 13(6):1108-1117. PubMed ID: 33538127
[TBL] [Abstract][Full Text] [Related]
18. In vitro metabolism of synthetic cannabinoid AM1220 by human liver microsomes and
Watanabe S; Kuzhiumparambil U; Fu S
Forensic Toxicol; 2018; 36(2):435-446. PubMed ID: 29963209
[TBL] [Abstract][Full Text] [Related]
19. In vitro metabolism of the novel synthetic opioid agonist cyclopropylfentanyl and subsequent confirmation in authentic human samples using liquid chromatography-high resolution mass spectrometry.
Cutler C; Hudson S
Drug Test Anal; 2019 Aug; 11(8):1134-1143. PubMed ID: 31081594
[TBL] [Abstract][Full Text] [Related]
20. Alkoxy chain length governs the potency of 2-benzylbenzimidazole 'nitazene' opioids associated with human overdose.
Glatfelter GC; Vandeputte MM; Chen L; Walther D; Tsai MM; Shi L; Stove CP; Baumann MH
Psychopharmacology (Berl); 2023 Dec; 240(12):2573-2584. PubMed ID: 37658878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
